Charlotte's Web Holdings Inc (CWEB:CA) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the Charlotte's Web Holdings Inc stock forecast from 0 analysts, the average analyst target price for Charlotte's Web Holdings Inc is not available over the next 12 months. Charlotte's Web Holdings Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Charlotte's Web Holdings Inc is Bearish, which is based on 2 positive signals and 9 negative signals. At the last closing, Charlotte's Web Holdings Inc’s stock price was CAD 0.27. Charlotte's Web Holdings Inc’s stock price has changed by -5.26% over the past week, +14.89% over the past month and -40.00% over the last year.
No recent analyst target price found for Charlotte's Web Holdings Inc
No recent average analyst rating found for Charlotte's Web Holdings Inc
Company Overview Charlotte's Web Holdings Inc
Charlotte's Web Holdings, Inc. is involved in the farming, manufacture, marketing, and sale of hemp-derived cannabidiol (CBD) wellness products. The company's products categories include hemp extract oil tinctures, such as liquid products; gummies; and capsules, CBD topical creams, and lotions, as well as products for pets under the Charlotte's Web, ReCreate, CBD Medic, CBD Clinic, and Harmony Hemp brands. Its products contain naturally occurring phytocannabinoids, including CBD, cannabichromene, cannabigerol, cannabinol, terpenes, flavonoids, and other beneficial hemp compounds. The company distributes its products through retail outlets and health care practitioners, as well as online through its website. It has a collaboration between its CW Labs science division and Colorado State University's College of Agricultural Sciences; and scientific collaboration with McLean Hospital. The company was formerly known as Stanley Brothers Holdings Inc. and changed its name to Charlotte's Web Holdings, Inc. in July 2018. The company was founded in 2013 and is headquartered in Louisville, Colorado. Address: 700 Tech Court, Louisville, CO, United States, 80027 Read Less
Charlotte's Web Holdings, Inc. is involved in the farming, manufacture, marketing, and sale of hemp-derived cannabidiol (CBD) wellness products. The company's products categories include hemp extract oil tinctures, such as liquid products; gummies; and capsules, CBD topical cream...Read More
Frequently Asked Questions About Charlotte's Web Holdings Inc (CWEB:CA) Stock
Stock Target Advisor's fundamental analysis for Charlotte's Web Holdings Inc's stock is Bearish.
Unfortunately we do not have enough data on CWEB:CA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on CWEB:CA's stock to indicate what its average analyst target is.
CWEB:CA stock's Price/Earning ratio is 120.37.
Our analysis grades CWEB:CA stock's Price / Earning ratio at F. This means that CWEB:CA stock's Price/Earning ratio is above 76% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the TSX exchange.
Based on this CWEB:CA may be a overvalued for its sector.
The last closing price of CWEB:CA's stock was CAD 0.27.
The most recent market capitalization for CWEB:CA is CAD 0.05B.
Unfortunately we do not have enough analyst data on CWEB:CA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Charlotte's Web Holdings Inc's stock.
As per our most recent records Charlotte's Web Holdings Inc has 164 Employees.
Charlotte's Web Holdings Inc's registered address is 1801 California Street, Denver, CO, United States, 80202.
You can get more information about it from Charlotte's Web Holdings Inc's website at https://www.charlottesweb.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CWEB:CA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
